LRMR - Moderna mRNA candidate chosen for FDA rare disease therapy acceleration program
2024-06-06 10:13:02 ET
More on Moderna
- Moderna: Betting On Bird Flu Rally Is A Poor Strategy For A Value Investor
- Bird flu death in Mexico linked to strain not seen in humans before
- FDA advisors unanimously agree on COVID JN.1-lineage vaccine for fall
- Moderna, Inc. (MRNA) Moderna Oncology Investor Event (Transcript)
- Moderna, Inc. (MRNA) Bernstein's 40th Annual Strategic Decisions Conference (Transcript)